Why the study?
The prevalence of TIA in the population is unclear due to uncertainty in diagnostic criteria, and there is a need to evaluate modern diagnostic and treatment methods including bleeding risk assessment during antithrombotic therapy.
Answers are grounded in this paper and cite their sources.
May support dual antiplatelet therapy in transient ischemic attack after bleeding assessment; leaves open prevalence estimates amid diagnostic uncertainty.
The article analyzes the current tendencies in the diagnosis and treatment of transient ischaemic attacks (TIA). The prevalence of TIA in the population has not been established due to the uncertainty of the diagnostic criteria. The authors discuss the problem of a qualitative diagnosis of TIA in detail. Based on the current clinical recommendations, modern and promising methods of treatment are discussed. The authors pay special attention to the assessment of the risk of bleeding during aggressive antithrombotic therapy.
No takes yet. Share an insight, caveat, or question.
Shirokov et al. (2021) conducted a review in Transient Ischaemic Attacks (TIA). Dual antiplatelet therapy (Aspirin + Clopidogrel) vs. Aspirin monotherapy was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: